New research in The FASEB Journal suggests that an abnormal amount of an inflammatory protein called PAR2 is present on abdominal fat tissues of overweight and obese humans and rats
Scientists have moved a step closer to an “obesity drug” that may block the effects of diets high in sugar and fats. In a new research report published in the December 2013 issue of The FASEB Journal, scientists show that there is an abnormal amount of an inflammatory protein called PAR2 in the abdominal fat tissue of overweight and obese humans and rats. This protein is also increased on the surfaces of human immune cells by common fatty acids in the diet. When obese rats on a diet high in sugar and fat were given a new oral drug that binds to PAR2, the inflammation-causing properties of this protein were blocked, as were other effects of the high-fat and high-sugar diet–including obesity itself.
“This important new finding links obesity and high fat high sugar diets with changes in immune cells and inflammatory status, highlighting an emerging realization that obesity is an inflammatory disease,” said David P. Fairlie, Ph.D., study author from the Institute for Molecular Bioscience at the University of Queensland, in Bribane, Australia. “Drugs designed to block certain inflammatory proteins, as in this report, may be able to prevent and treat obesity, which in turn is a major risk factor for type 2 diabetes, heart disease, stroke, kidney failure, limb amputation, and cancers.”
To make this discovery, Fairlie and colleagues discovered the first potent, selective and orally bioavailable small molecule antagonists of PAR2 and characterized their functional responses in inflammatory cellular and animal models. They found that PAR2 expression is increased in vivo in adipose tissue from obese humans and rats, stimulated in vitro in human macrophages by the dietary fatty acid palmitic acid, and inhibited in vivo and in vitro by a PAR2 antagonist. This antagonist was then used as a tool to dissect roles for PAR2 activation in mediating metabolic dysfunction in human monocyte-derived macrophages (HMDM), human and rodent adipocytes, and diet-induced obesity in rats. Oral treatment of diet-induced obese rats attenuated PAR2 signaling in adipose tissue and inhibited adipose inflammation, insulin resistance, diet-induced obesity and cardiovascular abnormalities. This is the first report that a PAR2 antagonist improves obesity, glucose homeostasis and obesity-associated chronic inflammation in vivo. These findings indicate that increased PAR2 expression may be a valuable new biomarker for metabolic dysfunction and further, that PAR2 antagonism can be an effective intervention for treating metabolic dysfunction and obesity.
“We know that that eating too much and not exercising enough makes you overweight, and then obese, but why? The bottom line of this report is that obesity is an inflammatory disease, and inflammation plays a greater role in the downward spiral to obesity than most people realize.” said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. “It appears that once we can control the inflammation, we can begin to get everything else in line. Fortunately, these scientists have already identified one promising compound that seems to work.”
The Latest on: Obesity is an inflammatory disease
- Night shifts work can raise risk of diabetes, obesityon May 11, 2024 at 6:24 am
Just three-night shifts may be enough to raise your risk of several diseases like diabetes, obesity, and other metabolic disorders, finds a study.Researchers from Washington State University, ...
- Obesity linked to 32 types of cancer as disease ‘fuels 40% of cases’, experts warnon May 10, 2024 at 12:00 pm
GETTING fat could be a factor in four out of 10 cancers, a major study has found. Experts say obesity can now be linked to 32 types of tumour – 19 more than previously thought. The ...
- Study shows how night shift work can raise risk of diabetes, obesityon May 9, 2024 at 12:55 pm
Just a few days on a night shift schedule throws off protein rhythms related to blood glucose regulation, energy metabolism and inflammation, processes that can influence the development of chronic ...
- How night shift work can raise risk of diabetes, obesityon May 9, 2024 at 12:39 pm
Just a few days on a night shift schedule throws off protein rhythms related to blood glucose regulation, energy metabolism and inflammation, processes that can influence the development of chronic ...
- Intermittent fasting protects against liver inflammation, liver cancer: Studyon May 9, 2024 at 5:18 am
Intermittent fasting has been found in multiple studies to be an effective way to lose weight and alleviate some metabolic disorders. Heikenwalder's team has now investigated in mice if this method ...
- Intermittent fasting halts liver disease progression and reduces cancer riskon May 8, 2024 at 11:13 pm
Fatty liver disease often leads to chronic liver inflammation and can even result in liver cancer. Scientists from the German Cancer Research Center (DKFZ) and the University of Tübingen have now ...
- Intermittent fasting protects against liver inflammation and liver cancer, claims studyon May 8, 2024 at 6:31 pm
Fatty liver disease often leads to chronic liver inflammation and can even result in liver cancer. Scientists from the German Cancer Research Center (DKFZ) and the University of Tübingen have ...
- Ask A Doctor: What Happens If Non-alcoholic Fatty Liver Disease Remain Untreated?on May 8, 2024 at 2:28 pm
Expert opinion from Marcelle Freire Doctor of Medicine · 3 years of experience · Brazil Non-alcoholic steatohepatitis is a medical term used to describe an inflammatory form of fatty degeneration of ...
- 5:2 fasting diet's anti-inflammatory effects come down to two proteinson May 8, 2024 at 12:38 am
A 5:2 intermittent fasting regime – eating for five days, fasting for two – protected against liver inflammation and didn’t cause weight gain, say researchers, who also identified the proteins that ...
- Obesity Newson May 7, 2024 at 5:00 pm
May 7, 2024 — Fatty liver disease often leads to chronic liver inflammation and can even ... for safely activating brown fat and tackling obesity and ... May 2, 2024 — Vigorous exercise ...
via Bing News
The Latest on: Inflammatory disease
- Inflammatory Bowel Disease Drugs Market To Surpass USD 27.65 Billion By 2031 Driven By Rising Prevalence Of IBD And Robust Pipeline Developmenton May 12, 2024 at 1:27 am
Gain insights into a market expected to surpass USD 27.65 billion by 2031, fueled by rising IBD prevalence and a robust pipeline of new drugs. Identify key growth drivers like rising adoption of ...
- Doctor shares tips for effective management of inflammatory bowel diseaseon May 10, 2024 at 11:40 am
Inflammatory Bowel Disease (IBD) causes inflammation and irritation in the digestive system. If you have been diagnosed with inflammatory bowel disease (IBD), Dr Meghraj Ingle, director and senior ...
- Why Obstetric History Matters When Assessing CV Risk in Women With Autoimmune Diseaseon May 9, 2024 at 3:26 am
A history of pregnancy complications can put women with autoimmune disease at a higher risk for CVD. Prophylaxis during pregnancy may avoid those complications in the first place.
- inflammatory protein research offers treatment strategies for a rare, potentially fatal lung diseaseon May 8, 2024 at 9:13 am
Most of the time, our immune systems do a great job defending against infection and keeping our bodies running smoothly. Sometimes, though, our immune system actually makes things worse. Case in point ...
- 7 Worst Inflammatory Foods Doctors Say Make Weight Loss 'So Much Harder': Sugary Condiments & Moreon May 7, 2024 at 11:30 am
Certain foods are notorious for their inflammatory properties, potentially making weight management more challenging and increasing the risk of chronic diseases. These “worst inflammatory foods” often ...
- A potential treatment for inflammatory bowel disease: Engineered yeast can transport medicines and lower inflammationon May 7, 2024 at 9:48 am
Inflammatory bowel disease (IBD) is a complex condition that requires individualized care to meet the needs of the patient's current disease state. With available medications sometimes causing serious ...
- My inflammatory bowel disease started as a bug but escalated quickly – I was in hospital for monthson May 7, 2024 at 4:24 am
AROUND 40,000 Irish people suffer with inflammatory bowel disease – but due to the nature of the condition, very few are open about it. One in five people in Ireland have IBD, and twice as ...
- Gut Bacteria Metabolite Battles Inflammatory Bowel Diseaseon May 6, 2024 at 4:59 pm
Furthermore, they observed that the enon (a functional group) FAs also suppressed prolonged T-cell proliferation and dendritic cell activation, which can lead to inflammation and autoimmune diseases.
- Risk for 'most' cardiovascular diseases no higher with inflammatory bowel disease, study findson May 6, 2024 at 4:20 am
Among postmenopausal women with inflammatory bowel disease (IBD), there is no higher risk for cardiovascular disease (CVD) compared with women without IBD, although the risk for ischemic stroke may be ...
- Inflammatory disease not major risk factors for severe COVID-19, focus on comorbidities urgedon May 3, 2024 at 5:30 am
Severe coronavirus disease 2019 (COVID-19) outcomes in patients with immune-mediated inflammatory diseases (IMIDs).
via Bing News